Rob Maloney: Over 104,000 USD Raised at The 2026 Trot to Clot
Rob Maloney, Chief Executive Officer of Hemophilia of Georgia, shared on LinkedIn:
”On May 16th, a small community did something remarkable.
Over 104,000 USD raised at the 2026 Trot to Clot.
I’ve said it before and I mean it every time.
It’s the big actions of a small community that make this work possible.
Every dollar raised goes toward our global impact program.
People living with bleeding disorders in underserved communities around the world who don’t have what our patients in Georgia have.
Access, support, a team that knows their name.
That gap is real. And events like this help close it.
To our sponsors, thank you. You make the starting line possible.
To our team captains, fundraisers, runners, walkers, volunteers, and donors.
You showed up. That matters more than you know.
This community never stops surprising me.
If you couldn’t make it this year but want to be part of what we’re building globally, there’s still a way in.
See you at the finish line next year.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering